CPPL

General Information


DRACP ID  DRACP05651

Peptide Name   CPPL

Sequence  MAPQRDTVGGRTTPPSWGPAKAQLRNSCA

Sequence Length  29

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C128H209N43O40S2

Absent amino acids  EFHIY

Common amino acids  AP

Mass  355406

Pl  11.38

Basic residues  4

Acidic residues  1

Hydrophobic residues  7

Net charge  3

Boman Index  -6628

Hydrophobicity  -82.76

Aliphatic Index  37.24

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  196.43

Polar residues  10

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22076844

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2620

DRACP is developed by Dr.Zheng's team.